Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00555204 · ClinicalTrials.gov registry record · Phase 2
Safety and Efficacy Study of ABT-089 in Adults With Mild to Moderate Alzheimer's Disease
A Phase 2 study, sponsored by Abbott.
- Terminated
- Registry status
- Phase 2
- Development phase
- 337
- Enrollment target
NCT00555204 is a Phase 2 study that was terminated before completion, run by Abbott. The registered enrollment target is 337 participants.
The verdict
NCT00555204, a Phase 2 study, was terminated before completion, sponsored by Abbott.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 337 participants
- Enrollment target
Study Summary
The purpose of this study is to test if the investigational medication ABT-089 is a safe and effective treatment for Alzheimer's disease.
Interventions
- DRUG ABT-089
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 337 participants |
| Start Date | 2007-11 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00555204
The ClinicalTrials.gov registry entry for NCT00555204 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 337 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abbott, which has 181 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which ABT-089 is the first listed.
NCT00555204 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00555204 about?
NCT00555204 is a clinical study titled "Safety and Efficacy Study of ABT-089 in Adults With Mild to Moderate Alzheimer's Disease". The purpose of this study is to test if the investigational medication ABT-089 is a safe and effective treatment for Alzheimer's disease.
What is the current status of trial NCT00555204?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 337 participants. The study started on 2007-11.
What interventions are being tested in trial NCT00555204?
The interventions under investigation include: ABT-089 (DRUG).
Who is sponsoring clinical trial NCT00555204?
This trial is sponsored by Abbott, which has 181 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.